In 2022, Alex Gorsky earned $10.09M in total compensation at Johnson & Johnson, including $1.49M salary, $2.39M bonus and $5.94M in stock. Most recently acquired 2,750 shares in Feb 2021. Currently holds stock worth $233.70M. Has donated $11.16M in stock to charitable causes. Led Johnson & Johnson as CEO for 9 years.
Compensation History
Annual executive compensation data for Alex Gorsky, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$10.09M
Salary
$1.49M
Bonus
$2.39M
Other
$268.99K
Salary
$1.49MBoard Justification
The compensation philosophy emphasizes alignment with company performance, shareholder interests, and retention of top talent through competitive compensation packages.
Bonus
$2.39MBoard Justification
The annual incentive payout for 2022 was based on a performance factor of 91.0% of target, reflecting the company's performance against financial and strategic goals.
Other Compensation
$268.99KBoard Justification
Other compensation includes perquisites such as personal use of corporate aircraft and contributions to retirement plans.
Restricted Stock
Board Justification
The stock awards granted in 2022 included Performance Share Units (PSUs) and Restricted Share Units (RSUs) that vested based on performance metrics.
Performance Metrics
The performance metrics for 2022 included operational sales, adjusted operational EPS, and free cash flow, with specific targets set for each.
Alex Gorsky
Ex-CEO of Johnson & Johnson
Education
Bachelor of Science from the U.S. Military Academy at West Point, NY; MBA from the Wharton School of the University of Pennsylvania
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
May 24, 1961 - 64 years ago
CEO of Johnson & Johnson for
9 years 8 months (Apr 2012 - Jan 2022)
Previous Experience
Joined Johnson & Johnson in 1988, held various positions including President of Janssen Pharmaceutica Inc. (U.S.) and Company Group Chairman for the pharmaceutical business in Europe, Middle East and Africa.
Holdings
Track Alex Gorsky's stock holdings and portfolio value over time.
Total Stock Sold
$38.61M
$38.61M
264,465 JNJ shares
What if they kept their stock?
If Alex Gorsky didn't sell their stock, today they would have:
Extra JNJ264,465 shares worth $53.40M.
This is 38.32% and $14.79M more than what they got when they sold the stock.
Charitable Transactions
55,287 shares
JNJ
Recent Charitable Transactions
12,640 shares
JNJ
Jan 14, 2022
Charity
20,950 shares
JNJ
Feb 8, 2021
Charity
13,674 shares
JNJ
Feb 8, 2019
Charity
7,153 shares
JNJ
Feb 9, 2018
Charity
870 shares
JNJ
Jan 16, 2013
Charity
Insider Trading
Alex Gorsky's recent stock transactions, purchases, and sales filed with the SEC.
12,640 shares
JNJ
Jan 14, 2022
Charity
20,950 shares
JNJ
Feb 8, 2021
Charity
2,750 shares
JNJ
Feb 8, 2021
Inheritance
12,127 shares
JNJ
Feb 8, 2019
Received
13,674 shares
JNJ
Feb 8, 2019
Charity
$38.60M
JNJ at $145.96/share
Nov 16, 2018
Sale
29,849 shares
JNJ
Feb 12, 2018
Received
7,153 shares
JNJ
Feb 9, 2018
Charity
33,635 shares
JNJ
Feb 13, 2017
Received
Rivals
Compare Alex Gorsky with competitor CEOs and industry peers.
Darren W. Woods
CEO of Exxon Mobil
2024 Compensation
Stock
$10.69M
Salary
$1.97M
Bonus
$4.55M
Other
$396.89K
Total Holdings
$421.98M
Albert Bourla
CEO of Pfizer
2024 Compensation
Stock
$0.00
Salary
$1.80M
Bonus
$7.02M
Other
$996.06K
Total Holdings
$18.14M
Robert M. Davis
CEO of Merck & Co.
2024 Compensation
Stock
$18.10M
Salary
$1.62M
Bonus
$0.00
Other
$561.11K
Total Holdings
$43.45M
Stanley C. Erck
CEO of Novavax
2023 Compensation
Stock
$129.78K
Salary
$50.90K
Bonus
$0.00
Other
$3.83M
Total Holdings
$4.60M
Stéphane Bancel
CEO of Moderna
2023 Compensation
Stock
$0.00
Salary
$1.58M
Bonus
$1.91M
Other
$1.07M
Total Holdings
$335.71M